Procter & Gamble Health Q1 Results Revenue rises to ₹28,388 lakhs, PAT decreases to ₹1,678 lakhs

Procter & Gamble Health Q1 Results 2024 - 2025: Procter & Gamble Health announced their Q1 results for the fiscal year 2024 - 2025 on August 21, 2024. The company saw a significant increase in revenue from ₹25,248 lakhs in the previous quarter to ₹28,388 lakhs, marking a 12.5% quarter-over-quarter growth.

This rise in revenue reflects a robust performance in their over-the-counter products, vitamins, minerals, and supplements segments. Despite the positive revenue growth, the company faced higher expenses, which rose from ₹19,203 lakhs in the last quarter to ₹24,299 lakhs, an increase of 26.7%.

This surge in expenses was attributed to higher materials and other operational costs. As a result, Procter & Gamble Health’s profit before tax decreased from ₹6,272 lakhs to ₹2,283 lakhs, highlighting the impact of increased costs on their overall profitability.

For More Q1 results check our Twitter Page

Procter & Gamble Health Q1 Results 2024 - 2025

Here’s a summary of Procter & Gamble Health's Q1 financial results for the fiscal year 2024 - 2025:

The company reported a notable increase in revenue but faced a rise in expenses, impacting its profit margins. Below is a detailed table showcasing the key financial figures for the quarter:

Source: Click Here

Procter & Gamble Health Current Market Overview

Procter & Gamble Health is currently performing well in the stock market. The company's share price is ₹5,211, with a market capitalization of ₹8,651 crore. The stock has fluctuated between ₹4,637 and ₹5,643 recently. It has a price-to-earnings ratio of 40.2, indicating strong profitability.

Investors enjoy a dividend yield of 0.96%, and the company shows impressive financial health with a return on capital employed of 44.9% and a return on equity of 33.4%. Overall, Procter & Gamble Health is considered a solid investment with good returns and stable performance.

Quarterly Results

Here’s a table summarizing the quarterly financial results for Procter & Gamble Health from December 2023 to June 2024:

About Procter & Gamble Health

Procter & Gamble Health is a leading company in India that focuses on producing and selling health products. Established as part of the Merck Group in 1967, it became a public company in 1981.

In 2018, Procter & Gamble acquired Merck’s Consumer Health business, making it a major player in the vitamins, minerals, and supplements market. The company offers a range of over-the-counter products designed to support a healthy lifestyle.

With a strong reputation and trusted brands, Procter & Gamble Health combines the expertise of both P&G and Merck to provide high-quality health solutions to millions of people.

Visit our website for more Q1 results.